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Exposure to second-hand smoke (SHS), also known as “passive smoking,” refers to a situation where 
a non-smoker inhales another person’s smoke either by sidestream or by mainstream exposure to 
tobacco smoke. Previous research has suggested that not only is prolonged exposure to SHS associ-
ated with a range of health-related problems similar to those found in smokers (1, 2) but is also 
linked to detrimental effects upon cognitive performance in children, adolescents, and adults. For 
example, children exposed to SHS show reduced vocabulary and reasoning skills when compared 
with non-exposed children (3) as well as more general cognitive and intellectual deficits (4). More 
recently, research using serum cotinine as a biomarker of exposure to SHS found that higher levels of 
serum cotinine were associated with significant reductions in performance in reading, mathematics, 
and visual and spatial abilities in children and adolescents (5) indicating that higher levels of SHS 
exposure is associated with poorer cognitive performance. In adults, exposure to SHS in those who 
had no history of smoking showed significantly reduced performance in processing speed (how 
quickly one can process information and perform tasks) and executive function (which includes 
the ability to organize memory, cognitive flexibility, and problem-solving ability) when compared 
with non-exposed, never smokers (6, 7). In addition, never smokers who lived with smokers for 
several decades showed a 30% increase in their risk of dementia (8). Recent work has also revealed 
everyday memory impairments in never smokers with a history of living with smokers for several 
years; for example, deficits in everyday prospective memory (memory for future actions), such as 
remembering to carry out everyday activities, keeping appointments with others, or remembering 
to post a letter on time (7, 9). What is less clear is the mechanism by which SHS might compromise 
cognitive performance.
The mechanisms underlying the links between SHS exposure and poorer cognitive performance 
are far from clear. One potential explanation derives from the notion that the carbon monoxide (CO) 
in tobacco smoke may interfere with the oxygen being delivered to the brain via the blood system. 
CO binds to human hemoglobin more than oxygen does; therefore, it is feasible that by inhaling 
tobacco smoke with a high level of CO across a prolonged period of time may diminish the amount 
of oxygen being carried to the brain, which may, in turn, lead to the range of cognitive impairments 
observed in the previous research. Although this hypothesis is somewhat speculative, it is a viable 
explanation and future work could test this by measuring levels of CO in the blood of never smokers 
who have been exposed to SHS and comparing these with never smokers with no history of such 
exposure. A second possible explanation stems from recent animal research, which has exposed 
animals to varying degrees of toxic mixtures of chemicals found in tobacco smoke. This research 
suggests that tobacco-specific procarcinogens may lead to reduced neuronal mass in specific regions 
of the brain associated with learning and memory; for example, in the hippocampal region of the 
brain, which is known to be involved in the mediation of memory and learning (10). Future research 
should therefore measure levels of procarcinogens, such as NKK, in SHS exposed individuals and 
whether these are associated with increasing cognitive deficits. A third possibility is that prolonged 
exposure to SHS may lead to a build-up of cardiovascular disease (CVD), which in turn may lead to 
a range of health and cognitive problems in later life. There is epidemiological evidence that shows 
prolonged exposure to SHS is associated with a greater increase in CVD (2, 11, 12). A longitudinal 
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design could elucidate this association by observing long-term 
exposure to SHS and a potential build-up of CVD and how these 
correlate with performance upon a range of cognitive measures.
Several limitations need to be considered when interpreting 
research in this area and designing future studies. The exposure 
to SHS in many studies is based on self-report measures, which 
may be subject to recall bias and lead to over- or underestimation 
of exposure. Biological assays could be used to provide more 
reliable estimates of SHS exposure, for example, cotinine residue 
levels or nicotine residue in saliva or hair samples. The use of 
other drugs should also be documented along with the exposure 
to SHS, because a large body of evidence now exists that docu-
mented the health and cognitive risks associated with the use of, 
for example, excessive amounts of alcohol, ecstasy, cannabis, and 
other substances. Other factors, such as socioeconomic status 
and personality variables such as impulsivity and risk-taking 
propensity, can impact upon health and cognition, so these too 
should be controlled for in future research.
In summary, the health problems associated with exposure to 
SHS in individuals who have no history of smoking are fairly well 
documented. More recently, studies have pointed to a range of 
cognitive consequences associated with SHS exposure, including 
everyday memory impairments. Our understanding of what the 
underlying mechanism(s) are that might account for such  cognitive 
deficits is in its infancy, and there is a great deal of scope for research 
that looks at the relationship between prolonged exposure to SHS, 
putative physical and neural damage, and the range of cognitive 
deficits documented in the literature. Given recent concerns raised 
by health bodies, such as the World Health Organization, about the 
risk SHS poses to children and adults around the world, it is clear 
that this is a topic that warrants further research.
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